Vogelxo Interactions
There are 178 drugs known to interact with Vogelxo (testosterone), along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 14 are major, 160 are moderate, and 4 are minor.
- View all 178 medications that may interact with Vogelxo
- View Vogelxo alcohol/food interactions (1)
- View Vogelxo disease interactions (11)
Most frequently checked interactions
View interaction reports for Vogelxo (testosterone) and the medicines listed below.
- Actemra (tocilizumab)
- Adasuve (loxapine)
- Adempas (riociguat)
- Afrezza (insulin inhalation, rapid acting)
- alosetron
- Aranesp (darbepoetin alfa)
- Blincyto (blinatumomab)
- buprenorphine
- Bydureon (exenatide)
- Caprelsa (vandetanib)
- Chantix (varenicline)
- Eliquis (apixaban)
- Entereg (alvimopan)
- Entyvio (vedolizumab)
- epoetin alfa
- Extraneal (lvp solution)
- Farydak (panobinostat)
- Fentanyl Transdermal System (fentanyl)
- Forteo (teriparatide)
- Gattex (teduglutide)
- Gilenya (fingolimod)
- Iclusig (ponatinib)
- Ionsys (fentanyl)
- isotretinoin
- Juxtapid (lomitapide)
- Krystexxa (pegloticase)
- Kynamro (mipomersen)
- Lemtrada (alemtuzumab)
- Letairis (ambrisentan)
- Lotronex (alosetron)
Vogelxo alcohol/food interactions
There is 1 alcohol/food interaction with Vogelxo (testosterone).
Vogelxo disease interactions
There are 11 disease interactions with Vogelxo (testosterone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- renal/liver disease
- diabetes
- hypercalcemia
- thyroid function tests
More about Vogelxo (testosterone)
- Vogelxo consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (7)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: androgens and anabolic steroids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.